|
US2017266246A1
|
|
Phytoestrogen product of red clover and pharmaceutical uses thereof
|
|
TW201625269A
|
|
Formulas comprising highly soluble elements and vitamin D for the prevention and treatment of bowel conditions during calcium supplementation
|
|
WO2015166468A1
|
|
Formulas comprising highly soluble elements and vitamin d for the prevention and treatment of bowel conditions during calcium supplementation
|
|
US2014296329A1
|
|
Phytoestrogen product of red clover and pharmaceutical uses thereof
|
|
WO2013050930A1
|
|
Development of a red clover phytoestrogen product for the prevention or treatment of osteoporosis
|
|
MX2014000957A
|
|
Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis.
|
|
AU2012288401A1
|
|
Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
|
|
US2011177179A1
|
|
Preparation of botanical extracts containing absorbable components using pharmaceutical platform technology
|
|
AU2008234619A1
|
|
Pharmaceutical platform technology for the development of natural products
|
